189 related articles for article (PubMed ID: 11565582)
1. CMV infection and disease in kidney and pancreas transplant recipients.
Keay S
Transpl Infect Dis; 1999; 1 Suppl 1():19-24. PubMed ID: 11565582
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
[TBL] [Abstract][Full Text] [Related]
3. Importance of CMV in the transplant population.
Rubin RH
Transpl Infect Dis; 1999; 1 Suppl 1():3-7. PubMed ID: 11565584
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection of the graft duodenum and urinary bladder after simultaneous pancreas-kidney transplantation.
Jang HJ; Kim SC; Cho YP; Kim YH; Han MS; Han DJ
Transplant Proc; 2004 Sep; 36(7):2200-2. PubMed ID: 15518799
[TBL] [Abstract][Full Text] [Related]
6. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients.
Stratta RJ; Alloway RR; Lo A; Hodge EE;
Transplant Proc; 2004 May; 36(4):1082-3. PubMed ID: 15194376
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
[TBL] [Abstract][Full Text] [Related]
8. Recurrent cytomegalovirus disease in solid-organ transplant recipients.
Falagas ME; Snydman DR
Transplant Proc; 1995 Oct; 27(5 Suppl 1):34-7. PubMed ID: 7482815
[TBL] [Abstract][Full Text] [Related]
9. The natural course of cytomegalovirus infection and disease in renal transplant recipients.
Hartmann A; Sagedal S; Hjelmesaeth J
Transplantation; 2006 Jul; 82(2 Suppl):S15-7. PubMed ID: 16858268
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection in seronegative patients treated with prophylaxis: case-controlled study.
Moreno de la Higuera Díaz MA; Calvo Romero N; Sánchez-Fructuoso A; Conesa J; Marques Vidas M; Prats D; Barrientos Guzmán A
Transplant Proc; 2007 Sep; 39(7):2231-2. PubMed ID: 17889147
[TBL] [Abstract][Full Text] [Related]
11. Indirect effects of CMV in the solid organ transplant patient.
Paya CV
Transpl Infect Dis; 1999; 1 Suppl 1():8-12. PubMed ID: 11565588
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection in simultaneous pancreas-kidney transplantation.
Malaise J; Ricart MJ; Moreno A; Crespo M; Fernández-Cruz L; Van Ophem D; Squifflet JP;
Transplant Proc; 2005; 37(6):2848-50. PubMed ID: 16182830
[TBL] [Abstract][Full Text] [Related]
14. Infectious complications after simultaneous pancreas-kidney transplantation.
Michalak G; Kwiatkowski A; Bieniasz M; Meszaros J; Czerwinski J; Wszola M; Nosek R; Ostrowski K; Chmura A; Danielewicz R; Lisik W; Adadynski L; Fesołowicz S; Dobrowolska A; Durlik M; Rowiñski W
Transplant Proc; 2005 Oct; 37(8):3560-3. PubMed ID: 16298661
[TBL] [Abstract][Full Text] [Related]
15. The problem of cytomegalovirus infection in renal allograft recipients.
Kurtz JB; Thompson JF; Ting A; Pinto A; Morris PJ
Q J Med; 1984; 53(211):341-9. PubMed ID: 6091169
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
17. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation.
San Juan R; Aguado JM; Lumbreras C; Fortun J; Muñoz P; Gavalda J; Lopez-Medrano F; Montejo M; Bou G; Blanes M; Ramos A; Moreno A; Torre-Cisneros J; Carratalá J;
Clin Infect Dis; 2008 Oct; 47(7):875-82. PubMed ID: 18752439
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
[TBL] [Abstract][Full Text] [Related]
19. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
Legendre C; Pascual M
Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
[TBL] [Abstract][Full Text] [Related]
20. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
